GSK Seeks to Consolidate Zofran Lawsuits Alleging Birth Defects
GlaxoSmithKline has filed a motion with the U.S. Judicial Panel on Multidistrict Litigation (JPML) to consolidate all federal Zofran lawsuits for coordinated pretrial proceedings. As the number of product liability lawsuits filed on behalf of children born with heart defects, cleft palate and other congenital defects allegedly caused by exposure... Read more »